These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5893249)

  • 41. Response of 9L tumor cells in vitro to spirohydantoin mustard.
    Deen DF; Hoshino T; Williams ME; Nomura K; Bartle PM
    Cancer Res; 1979 Nov; 39(11):4336-40. PubMed ID: 498067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative antitumor effects of peptichemio and other alkylating agents.
    Schmid FA; Banks SE; Stock CC
    Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
    Mal'tseva LF
    Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
    [No Abstract]   [Full Text] [Related]  

  • 44. The effects of nitrogen mustard and dimethyl myleran on murine leukemia cell lines of different radiosensitivity in vitro.
    Goldenberg GJ; Alexander P
    Cancer Res; 1965 Oct; 25(9):1401-9. PubMed ID: 5861070
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of nitrogen mustard on circulating cancer cells and pulmonary metastases from an experimental cecal carcinoma.
    CLIFFTON EE; AGOSTINO D
    Surg Gynecol Obstet; 1961 Aug; 113():160-6. PubMed ID: 13694104
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
    Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
    Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental study on the antitumoral activity of some N-mustards derivatives of the L-asparagic acid.
    Năstasă V; Sunel V; Dăneţ D; Dăneţ R
    Rev Med Chir Soc Med Nat Iasi; 1983; 87(4):619-22. PubMed ID: 6676886
    [No Abstract]   [Full Text] [Related]  

  • 48. [Determination of the effective dose for the in-vitro destruction of Ehrlich mice ascites carcinoma cells by nitrogen mustard oxide].
    von Ardenne M; Reitnauer PG
    Acta Biol Med Ger; 1966; 16(1):43-53. PubMed ID: 5974487
    [No Abstract]   [Full Text] [Related]  

  • 49. [Animal experimental examination of a phase III study on the effect of the combination therapy of bruneomycin, cytostasan and prednisone].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1983; 53(1):37-44. PubMed ID: 6344835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The significance of connective tissue stimulation in antitumor chemotherapy].
    Diadosha GF; Bulkina ZP; Kononenko LI
    Vopr Onkol; 1968; 14(9):70-3. PubMed ID: 4971964
    [No Abstract]   [Full Text] [Related]  

  • 51. [The antineoplastic activity of testiphenon].
    Lagova ND; Sof'ina ZP; Shkodinskaia EN; Kurdiumova KN; Valueva IM
    Vopr Onkol; 1988; 34(11):1363-8. PubMed ID: 3201773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cure of mice bearing advanced plasma cell tumours with aniline mustard.
    Whisson ME; Connors TA
    Nature; 1965 May; 206(985):689-91. PubMed ID: 5832853
    [No Abstract]   [Full Text] [Related]  

  • 53. Response of cultured 9L cells to spirohydantoin mustard and X-rays.
    Deen DF; Bartle PM; Williams ME
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1663-7. PubMed ID: 536274
    [No Abstract]   [Full Text] [Related]  

  • 54. Attempts to use albumin as a carrier of L-phenylalanine mustard.
    Larsen B
    Eur J Cancer (1965); 1967 Jun; 3(2):163-4. PubMed ID: 6046496
    [No Abstract]   [Full Text] [Related]  

  • 55. The synthesis of some aryl nitrogen mustard derivatives of estrogens.
    Walk CR; Chou TC; Lin HH
    J Med Chem; 1967 Mar; 10(2):255-7. PubMed ID: 6034071
    [No Abstract]   [Full Text] [Related]  

  • 56. [Study of injection solutions of phenesterin prepared in nonaqueous solutions].
    Korostin VI; Lopatin PV; Kudakova NA; Kondrat'eva TS
    Farmatsiia; 1975; 24(1):43-6. PubMed ID: 1222772
    [No Abstract]   [Full Text] [Related]  

  • 57. A study on immunological therapy for cancer by using nitrogen mustard-treated cancer tissue.
    Asakuma R; Yokoyama I
    Nihon Geka Hokan; 1965 Nov; 34(6):1413-29. PubMed ID: 5893249
    [No Abstract]   [Full Text] [Related]  

  • 58. [Tumour chemotherapy: syntheses of N-phosphorylated nitrogen mustards and related compounds].
    Kao WI; Ho HY; Song CW; Li MM; Cheng BL
    Yao Xue Xue Bao; 1965 Oct; 12(10):672-7. PubMed ID: 5898992
    [No Abstract]   [Full Text] [Related]  

  • 59. Potential anticancer agents. I. A nitrogen mustard based on orotic acid.
    Danielsson B; Bogentoft C; Ljungnér F
    Acta Pharm Suec; 1968 Sep; 5(4):279-82. PubMed ID: 5724370
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experimental study of the anti-tumoral activity of some azotyperites with N-benzoyl asparagic acid derivative support].
    Budeanu CH; Sunel V; Iancu I; Dăneţ D; Dăneţ R
    Rev Med Chir Soc Med Nat Iasi; 1973; 77(4):817-23. PubMed ID: 4781132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.